每經AI快訊(xun)，4月(yue)18日(ri)，恒瑞醫藥公(gong)(gong)告，公(gong)(gong)司收到美(mei)國(guo)食品(pin)藥品(pin)監督(du)管(guan)(guan)理(li)局(ju)（以下(xia)簡稱“FDA”）的(de)認證函，公(gong)(gong)司項(xiang)目注(zhu)射用SHR-A2102獲得(de)美(mei)國(guo)FDA授予快速通道資格。公(gong)(gong)司同日(ri)公(gong)(gong)告，收到國(guo)家藥品(pin)監督(du)管(guan)(guan)理(li)局(ju)核準簽發(fa)關于SHR-3276注(zhu)射液的(de)《藥物臨床(chuang)試(shi)驗(yan)批準通知(zhi)書(shu)》。